IIM
XBI icon

IFC & Insurance Marketing’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

IFC & Insurance Marketing’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-50
Closed -$6K – 705
2025
Q4 		$6K Buy
+50
New +$5.73K 0.01% 490

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

IFC & Insurance Marketing's XBI Position: Q1 2026 in Review

IFC & Insurance Marketing sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 50 shares — an estimated $6K sold.

IFC & Insurance Marketing first reported a position in XBI in Q4 2025 and held it in 1 quarter. The position peaked at $6K in Q4 2025. 816 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • IFC & Insurance Marketing reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
  • IFC & Insurance Marketing sold 50 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $6K.
  • IFC & Insurance Marketing first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and held it in 1 quarter.
  • IFC & Insurance Marketing's State Street SPDR S&P Biotech ETF position peaked at $6K in Q4 2025.
  • 816 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on IFC & Insurance Marketing's 13F filing for Q1 2026, filed 17 Apr 2026.